As an example, in triple damaging breast cancer (TNBC),twenty five and in hepatocellular carcinoma,26 DNA methylation profiles have aided into the identification of unique subgroups with clinical relevance. Epigenetic methods have also aided to the event of prognostic exams to assess the sensitivity of cancer cells to certain medicines.27 https://directivepublications.org/world-journal-of-clinical-cancer-research/